Entrepreneurship

Filter by Region, Sector, or Focus
The W.L. Lyons Brown III Innovation Laboratory, or i.Lab at UVA supports entrepreneurs and innovators both on and beyond the UVA Grounds.
Local biotechnology industry leader Nikki Hastings, PhD, has been named the first Executive Director of the CvilleBioHub, a non-profit that connects and supports the Charlottesville-area biotechnology sector.  CvilleBioHub will receive strategic pla
The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners. 
PsiKick is utilizing revolutionary ultra-low-power technologies from the Universities of Virginia and Michigan to build completely self-powered sensing systems that do not require batteries, can be deployed nearly anywhere, and unlock new data stream
Mission Secure Inc. recently announced the closing of an $8 million Series A financing round led by Energy Innovation Capital and Chevron Technology Ventures.
Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.
Darden offers over 35 elective courses in entrepreneurship and innovation, four major entrepreneurial competitions awarding more than $370,000 annually, and an incubator program know as the i.Lab.
Darden's Executive MBA and Global Executive MBA programs will now operate primarily from a new state-of-the-art facility in the Rosslyn district of Arlington, VA.
UVA, Albemarle County, and the City of Charlottesville pledged support for a program aimed at accelerating the growth of local startups.
Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).
The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.